Skip to main content
. Author manuscript; available in PMC: 2011 May 3.
Published in final edited form as: Clin Cancer Res. 2008 Sep 1;14(17):5602–5609. doi: 10.1158/1078-0432.CCR-08-0433

Table 4.

Pharmacokinetic variables of EKB-569 and N-desmethyl EKB-569 on day 8

Compound Cmax (ng/mL) Tmax (h) T1/2 (h) AUC (ng·h/mL) Cl/F (L/h) Vss/F (L)
EKB569 42.3 ± 15.1 4 (2–8) 16.6 ± 3.7 633 ± 234 57 ± 24 1,295 ± 445
N-Demethy EKB-569 4.2 ± 3.2 3.5 (2–6) 24.1 ± 9.2 64.4 ± 43.3

NOTE: Values are mean ± SD except for Tmax, which are mean and range.

Abbreviations: Tmax, time to Cmax; Cl/F, oral clearance; Vss/F, volume of distribution at steady-state after p.o. administration.